Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04332744
Title Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) (ZZ-First)
Acronym ZZ-First
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.